Search

Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More

BIO ROUNDUP: DUCHENNE DATA, ROCHE BUYS FOUNDATION, IPO WAVE & MORE

Biotech financing is a cyclical thing. Two years ago, the IPO window was unlatched but a number of companies ended up withdrawing their...

PROJECT MANAGER - BACHEM INC - VISTA, CA

The company provides a full range of services to the pharma and biotech industries. Schedule, organize, and document customer visits...

 
 
 
New approaches to oncology may require new approaches to clinical trials

NEW APPROACHES TO ONCOLOGY MAY REQUIRE NEW APPROACHES TO CLINICAL TRIALS

Targeted therapies have potential to be highly effective. The challenge is finding patients to enroll in clinical trials.

 
 
 
Lawsuit aims to hold pharmaceutical executives accountable in opioid crisis

LAWSUIT AIMS TO HOLD PHARMACEUTICAL EXECUTIVES ACCOUNTABLE IN OPIOID CRISIS

OxyContin manufacturer Purdue Pharma and its executives are targeted in a new legal action.

Pharma giants like Novartis, Pfizer, and Sanofi are getting serious about a cutting edge therapy that changes human genes

PHARMA GIANTS LIKE NOVARTIS, PFIZER, AND SANOFI ARE GETTING SERIOUS ABOUT A CUTTING EDGE THERAPY THAT CHANGES HUMAN GENES

Pharma is getting serious about gene therapy, one-time treatments that modify genes to potentially cure serious diseases. Novartis...

 
 
 
CAR-T has a lot of promise, but some big challenges remain, experts at BIO, ASCO say

CAR-T HAS A LOT OF PROMISE, BUT SOME BIG CHALLENGES REMAIN, EXPERTS AT BIO, ASCO SAY

Many issues around CAR-T remain to be hashed out, but many experts pointed to infrastructure and clinics' capabilities as crucial.

A $940 million startup that VCs initially rejected is trying to do for pharma what it did for Netflix

A $940 MILLION STARTUP THAT VCS INITIALLY REJECTED IS TRYING TO DO FOR PHARMA WHAT IT DID FOR NETFLIX

Five-year-old data-crunching startup Databricks is worth $940 million after its Apache Spark software went viral among companies ranging...

 
 
 
Bluebird shares recover after slump following ASCO CAR-T data presentation

BLUEBIRD SHARES RECOVER AFTER SLUMP FOLLOWING ASCO CAR-T DATA PRESENTATION

Progression-free survival rates from bb2121 in multiple myeloma still impress despite investor reaction.

Session at ASCO shows community oncology success in precision medicine

SESSION AT ASCO SHOWS COMMUNITY ONCOLOGY SUCCESS IN PRECISION MEDICINE

Experts went into the nitty-gritty aspects of how the community oncology setting can implement precision medicine trials.

 
 
 
Updated ASCO data from Loxo study show more patients responding

UPDATED ASCO DATA FROM LOXO STUDY SHOW MORE PATIENTS RESPONDING

Interim data from the Phase I data show 77 percent overall response rate, including 74 percent confirmed responses.

Propeller Health Raises $20M to Move Beyond Respiratory Disease

PROPELLER HEALTH RAISES $20M TO MOVE BEYOND RESPIRATORY DISEASE

Since launching in 2010, Propeller Health has kept its focus on developing connected devices and complementary software for patients...

 
 
 
A confidential report reveals that Purdue Pharma knew OxyContin was being abused within the first few years after it launched

A CONFIDENTIAL REPORT REVEALS THAT PURDUE PHARMA KNEW OXYCONTIN WAS BEING ABUSED WITHIN THE FIRST FEW YEARS AFTER IT LAUNCHED

Thomson Reuters A New York Times investigation found after uncovering a chain of confidential internal communications that Purdue Pharma...

Start-up plans to target epilepsy using gut microbiota

START-UP PLANS TO TARGET EPILEPSY USING GUT MICROBIOTA

Bloom Science plans to have its proprietary gut bacteria in the clinic for hard-to-treat patients in next 12-18 months.

 
 
 
'Pharma Bro' Martin Shkreli had $7 million of his assets seized when he was sent to prison - and people are arguing over who gets the first slice

'PHARMA BRO' MARTIN SHKRELI HAD $7 MILLION OF HIS ASSETS SEIZED WHEN HE WAS SENT TO PRISON - AND PEOPLE ARE ARGUING OVER WHO GETS THE FIRST SLICE

Pharmaceutical CEO Martin Shkreli was convicted of securities fraud earlier this year. A court ordered him to forfeit $7.36 million...

 
 
 

BUYER - REMX SPECIALTY STAFFING - SAN DIEGO, CA

5 years minimum of experience as a Buyer, preferably within the Medical Device, Pharma, Biotech industry. Maintains work area in a...

 
 
 
Novartis attorney retires over payments to Trump attorney Michael Cohen

NOVARTIS ATTORNEY RETIRES OVER PAYMENTS TO TRUMP ATTORNEY MICHAEL COHEN

Felix Ehrat steps down amid controversy over $1.2 million in payments to Trump attorney that the Swiss drug maker disclosed last week.